Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Sci Adv. 2024 Aug 23;10(34):eadl3975. doi: 10.1126/sciadv.adl3975. Epub 2024 Aug 21.
Genetic (A20) inactivation is a classical somatic lymphoma lesion and the genomic trait in haploinsufficiency of A20 (HA20). In a cohort of 34 patients with HA20, we show that heterozygous loss skews immune repertoires toward lymphocytes with classical self-reactive antigen receptors typically found in B and T cell lymphomas. This skewing was mediated by a feed-forward tumor necrosis factor (TNF)/A20/nuclear factor κB (NF-κB) loop that shaped pre-lymphoma transcriptome signatures in clonally expanded B (, , and ) or T (, , and ) cells. The skewing was reversed by anti-TNF treatment but could also progress to overt lymphoma. Analysis of conditional knock-out mice reproduced the wiring of the TNF/A20/NF-κB signaling axis with permissive antigen receptors and suggested a distinct regulation in B and T cells. Together, patients with the genetic disorder HA20 provide an exceptional window into A20/TNF/NF-κB-mediated control of immune homeostasis and early steps of lymphomagenesis that remain clinically unrecognized.
(A20)基因失活是经典的体细胞淋巴瘤病变,也是 A20(HA20)杂合不足的基因组特征。在一组 34 名 HA20 患者中,我们表明杂合性缺失会使免疫反应偏向于具有经典自身反应性抗原受体的淋巴细胞,这些受体通常存在于 B 和 T 细胞淋巴瘤中。这种偏向是由肿瘤坏死因子 (TNF)/A20/核因子 κB (NF-κB) 正反馈环介导的,该环塑造了克隆扩增的 B(、、和)或 T(、、和)细胞中的淋巴瘤前转录组特征。抗 TNF 治疗可逆转这种偏向,但也可能进展为明显的淋巴瘤。条件性 敲除小鼠的分析再现了 TNF/A20/NF-κB 信号轴与允许性抗原受体的连接,并提示 B 和 T 细胞存在不同的调节。总之,患有遗传疾病 HA20 的患者为 A20/TNF/NF-κB 介导的免疫稳态控制和淋巴瘤发生的早期步骤提供了一个特殊的窗口,这些步骤在临床上尚未得到认识。